FormFactor vs Ichor
FORM and ICHR side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FORM and ICHR compare
FormFactor is the larger company, worth 5.1 times as much as Ichor ($6.8B against $1.3B).
FormFactor grew revenue faster over the last twelve months (29.1% versus 9.1% for Ichor).
FormFactor keeps more of each dollar of sales as profit, with a net margin of 17.7% compared with −4.0% at Ichor.
FormFactor scores higher on the StockData Score (14 against 6 for Ichor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FORM | ICHR |
|---|---|---|
| Size and price | ||
| Market cap | $6.8B | $1.3B |
| Share price | $87.53 | $35.72 |
| Change, 1 year | 69.5% | 121% |
| Change, 5 years | 104% | −27.4% |
| Beta (5Y) | 1.70 | 2.17 |
| Employees | 2,153 | 1,891 |
| StockData Score | ||
| Total score | 14 (better) | 6 |
| Valuation score | 2 (better) | 1 |
| Growth score | 3 (better) | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 5 (better) | 4 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 40.0× | – |
| P/S | 7.0× | 1.3× (better) |
| P/B | 5.8× | 1.5× (better) |
| EV/EBITDA | 35.9× (better) | 144× |
| P/FCF | 37.7× | – |
| PEG | 19.88 | – |
| FCF yield | 2.7% (better) | −1.9% |
| Fair value | $74.96 | $6.86 |
| Margin of safety | −16.8% (better) | −420% |
| Growth | ||
| Revenue growth (TTM) | 29.1% (better) | 9.1% |
| Revenue growth, 5Y average | 2.5% (better) | 0.72% |
| Net income growth (TTM) | 325% | – |
| EPS growth (TTM) | 321% | – |
| EPS growth, 5Y average | −7.0% | – |
| Profitability | ||
| Gross margin | 47.1% (better) | 10.4% |
| Operating margin | 18.3% (better) | −2.4% |
| Net margin | 17.7% (better) | −4.0% |
| FCF margin | 18.5% (better) | −2.5% |
| Return on equity | 15.8% (better) | −5.2% |
| Return on invested capital | 20.2% (better) | −2.6% |
| Financial health | ||
| Debt / equity | 0.01 (better) | 0.14 |
| Net debt / EBITDA | −2.14 | −16.32 |
| Interest coverage | – | −3.7× |
| Current ratio | 3.68 | 3.70 (better) |
| Altman Z-score | 18.24 (better) | 3.91 |
| Piotroski F-score | 5 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | 0.00% | – |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 92.4% | 90.0% |
| Held by insiders | 0.87% | 2.9% |
| Insider net buying, 12 months | −$22.9M | −$14.0M (better) |
| Short interest, % of float | 3.6% | 10.0% |
Go deeper
- FORM stock overview
- FORM income statement
- FORM valuation and score
- ICHR stock overview
- ICHR income statement
- ICHR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.